The Number Every Person With Gout Needs to Know
Three. That’s the number.
If you’re having more than three treated gout flares a year, your heart may be in danger for years to come. Not next decade. Not eventually. Right now, and for at least seven years.
A new study published in Rheumatology in July 2026 tracked 44,705 adults with gout and found something that should change how every doctor thinks about flare frequency. Having more than three flares annually doesn’t just mean your joints hurt more often. It means your risk of heart failure, stroke, and heart attack stays elevated for years.
And almost nobody is talking about it.
The Study That Changes the Conversation
Researchers pulled electronic health records from the TriNetX Global Collaborative Network, a massive database that spans multiple countries and healthcare systems. They focused on people who had their first recorded treated gout flare in 2017 and followed them for up to seven years.
Here’s how they split the group:
- Low frequency: three or fewer treated flares per year
- Moderate frequency: four to six flares per year
- High frequency: seven or more flares per year
They excluded anyone who already had a heart attack, stroke, or heart failure before the study started. That way, they could track new cardiovascular events and see whether flare frequency predicted them.
It did. In a big way.
What the Numbers Actually Say
Let’s break it down.
People in the high-frequency group (seven or more flares per year) had a 45% greater risk of major adverse cardiovascular events over seven years compared to those in the low-frequency group. That includes heart failure, stroke, and heart attack combined.
Even the moderate group (four to six flares) wasn’t safe. They showed a 24% increase in cardiovascular risk.
By year seven, 18.6% of the high-flare group had experienced a major cardiovascular event. Compare that to 12.9% in the low-flare group. That’s not a small gap. That’s nearly six extra people out of every hundred having a serious heart event.
Heart failure turned out to be the most sensitive warning sign. People with four to six flares per year had a 17% higher risk of heart failure over seven years. Those with seven or more had a 27% increased risk.
Stroke and heart attack followed a different pattern. They only became significantly more common in the highest flare group. Stroke risk showed up after about three years. Heart attack risk took longer, emerging around year five.
The researchers suggested that different cardiovascular problems may need different amounts of inflammatory damage before they become clinically visible. Heart failure shows up first. Strokes and heart attacks take longer.
Why Your Heart Takes the Hit
It comes down to inflammation. Not the kind you feel in your toe. The kind that quietly damages your blood vessels and heart muscle.
Every gout flare is triggered by uric acid crystals activating something called the NLRP3 inflammasome. Think of it as an alarm system inside your immune cells. When uric acid crystals set it off, your body releases inflammatory messengers like interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha.
One flare? Your body handles it. But repeated flares, year after year? That constant inflammatory signaling starts damaging the lining of your blood vessels. It contributes to plaque buildup in arteries. It affects how your heart muscle remodels itself. Over time, that damage accumulates.
Heart failure may show up first because inflammation directly affects the heart muscle’s structure and function, causing fibrosis and stiffening. Strokes and heart attacks, which depend more on plaque rupture and blood clots, may require more cumulative damage before they occur.
If you want to understand more about how gout silently damages your body between attacks, read our deep dive on gout damage between flares.
The Three-Flare Threshold
The researchers proposed a specific number: more than three treated flares per year should serve as a flag for cardiovascular risk assessment.
This is different from the treatment threshold. The American College of Rheumatology already recommends starting urate-lowering therapy when you have two or more flares per year. The new three-flare threshold isn’t about when to start medication. It’s about identifying who needs closer heart monitoring.
Think of it this way. Two flares a year means your doctor should be talking about lowering your uric acid. Three or more means your doctor should also be checking your blood pressure, cholesterol, and heart function.
The distinction matters because many people with frequent flares already carry other cardiovascular risk factors. High blood pressure, diabetes, and kidney disease are common in people with gout. Adding frequent flares on top of that stack creates a dangerous combination.
If you have kidney disease alongside gout, the risks compound even faster. Our guide on gout and kidney disease explains why this two-way relationship matters.
What This Means for Your Next Doctor Visit
So what should you actually do with this information?
Count your flares. Not just the ones that send you to the ER. The ones you treat at home count too. The study likely underestimated total flares because it only captured treated episodes in medical records. If you’re managing flares with leftover colchicine or over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) without seeing a doctor, those still count.
Talk to your doctor about your heart. If you’re having more than three flares a year, ask for a cardiovascular risk assessment. That might include blood pressure checks, lipid panels, and possibly an echocardiogram to look at your heart function.
Take urate-lowering therapy seriously. The best way to reduce flare frequency is to get your serum urate below 6 mg/dL and keep it there. If you’re wondering whether you can ever stop taking gout medication, the largest study on the topic has some surprising answers. Check out our coverage of when it’s safe to stop gout medication.
Don’t ignore flares between attacks. Gout doesn’t go silent between flares. Inflammation continues to simmer, quietly damaging joints and blood vessels. This is why persistent flares and the heart connection go hand in hand.
The Bigger Picture: Gout Is a Whole-Body Disease
This study adds to what we already know about gout. It’s not just a joint problem. It’s a systemic inflammatory condition with real consequences for your heart and blood vessels.
Previous research showed that cardiovascular events are more likely in the first two weeks after an acute gout flare. But those studies treated each flare as an isolated event. This new study asks a different question: does the pattern of frequent flares identify ongoing cardiovascular vulnerability?
The answer is yes. And the risk persists for years, not just during or immediately after a flare.
This also connects to what we already know about gout and stroke risk. Our earlier article on gout and stroke explored the hidden connection between uric acid and brain health. The new flare-frequency data adds another layer: it’s not just whether you have gout, but how often it flares.
What the Study Can’t Tell Us
It’s worth noting the limitations. This was an observational study based on electronic health records. It can show association, but not prove that frequent flares directly cause heart disease.
The flare count relied on treated episodes in medical records, which means home-managed flares weren’t captured. Real flare frequency is almost certainly higher than what the study recorded.
The study also didn’t account for treatment changes after the first year. If someone started urate-lowering therapy or colchicine prophylaxis during follow-up, that could have influenced outcomes.
Still, sensitivity analyses using stricter flare definitions produced similar results. The association holds up.
The Bottom Line
Three flares a year. That’s the number to remember.
If you’re above that threshold, you need more than joint pain management. You need a conversation about your heart. And if you’re having seven or more flares a year, the data suggests your cardiovascular risk stays elevated for at least seven years.
The good news? Reducing flare frequency is achievable. Urate-lowering therapy works. Lifestyle changes help. And now you have a concrete reason to take it seriously that goes beyond joint pain.
Your joints will thank you. Your heart might too.

Frequently Asked Questions
How many gout flares per year is considered dangerous?
According to the 2026 study in Rheumatology, more than three treated flares per year is associated with a sustained increase in cardiovascular risk. People with seven or more flares annually had a 45% greater risk of major cardiovascular events over seven years.
Does reducing gout flares lower heart risk?
The study couldn’t directly prove that reducing flares lowers cardiovascular risk because it was observational. However, the biological mechanism makes sense: fewer flares mean less inflammatory burden on your blood vessels and heart. Future interventional studies are needed to confirm this.
Should I see a cardiologist if I have frequent gout flares?
If you’re having more than three flares per year, it’s worth asking your primary care doctor or rheumatologist about a cardiovascular risk assessment. This might include blood pressure monitoring, cholesterol testing, and evaluation of heart function. You don’t necessarily need a cardiologist right away, but you do need someone to assess your overall cardiovascular risk.
What’s the difference between the gout treatment threshold and the cardiovascular risk threshold?
The American College of Rheumatology recommends starting urate-lowering therapy at two or more flares per year. The new three-flare threshold from this study is specifically for cardiovascular risk stratification. It identifies who needs closer heart monitoring, not just who needs gout medication.
Why does gout affect the heart?
Uric acid crystals activate the NLRP3 inflammasome, triggering release of inflammatory cytokines like interleukin-1 beta. Repeated flares sustain this inflammatory response, which can damage blood vessel linings, promote plaque buildup, and affect heart muscle function. Heart failure appears to be the most sensitive to this inflammatory damage.
References
- Tung KT, et al. “Annual gout flare frequency as a marker of sustained cardiovascular risk: a clinical threshold for risk stratification.” Rheumatology. July 2026. doi:10.1093/rheumatology/keag370
- Cipolletta E, et al. “Association between gout flare and subsequent cardiovascular events among patients with gout.” JAMA. 2022;328(5):440-450.
- FitzGerald JD, et al. “2020 American College of Rheumatology Guideline for the Management of Gout.” Arthritis Care & Research. 2020;72(6):731-758.
- Kojima S, et al. “Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED).” European Heart Journal. 2019;40(24):1778-1786.
- Finnikin S, Mallen CD, Roddy E. “Gout flares, serum urate and seasonality: a descriptive cohort study.” Clinical Rheumatology. 2026;45:1439-1448.
- Choi HK, et al. “Gout and cardiovascular disease: what do we know?” Current Opinion in Rheumatology. 2021;33(2):143-150.
Reviewed by the GoutSavvy Editorial Team